It's a girl — again! And again! Why a baby's sex isn't random.
A study published Friday in the journal Science Advances describes the odds of having a boy or girl as flipping a weighted coin, unique to each family. It found evidence that an infant's birth sex is associated with maternal age and specific genes.
Subscribe to The Post Most newsletter for the most important and interesting stories from The Washington Post.
The findings challenge assumptions that birth sex is random. They mirror the results of similar studies in Europe that have also found that birth sex does not follow a simple 50-50 distribution.
Scientists have long documented a global imbalance in which slightly more boys are born than girls. The new study examined the murkier patterns of birth sex within individual families.
To do so, researchers at the Harvard T.H. Chan School of Public Health analyzed data from more than 146,000 pregnancies from 58,000 nurses in the United States between 1956 and 2015. They found that some families were more likely to have children of the same sex than would be expected if each baby had an equal chance of being a boy or a girl. Moms with three or more kids were more likely to have all boys or all girls than expected by chance.
The study suggests that sex at birth follows a weighted probability and that biological influences may sway the sex of the child.
'If you've had two girls or three girls and you're trying for a boy, you should know your odds are not 50-50,' said Jorge Chavarro, the study's senior author. 'You're more likely than not to have another girl.'
Researchers estimated that families with three girls had a 58 percent chance of having another girl, while families with three boys had a 61 percent chance of having a fourth boy.
Maternal age is a key factor. Women who started having children after age 28 were slightly more likely to have only boys or only girls. Chavarro said this could reflect age-related biological changes that influence the survival of the Y chromosome carried by boys, such as increased vaginal acidity. Paternal factors could also play a role because maternal and paternal ages are often closely linked. But the study did not include data on fathers, which was noted as a limitation.
Researchers also identified two genes associated with giving birth to only boys or only girls. 'We don't know why these genes would be associated with sex at birth, but they are, and that opens up new questions,' Chavarro, a professor of nutrition and epidemiology, said.
Iain Mathieson, a professor of genetics at the University of Pennsylvania Perelman School of Medicine who was not involved in the study, said the genetic associations should be viewed cautiously. He said the study's genetic analysis was based on a relatively small sample and may be influenced by other factors, making the results more speculative until confirmed by further research.
'I don't find the genetic factors identified here particularly convincing,' Mathieson said in an email.
The researchers also found that parents were more likely to have one boy and one girl than would be expected by chance, a pattern they believe reflects a tendency to stop having children once both sexes are represented.
To reduce bias from such family planning decisions, they analyzed data after removing each woman's final child. They also excluded women who had experienced miscarriages or stillbirths to test whether pregnancy loss changed the results. They still found the same pattern: The odds of birth sex did not follow mere chance.
The study suggests it may not have been so improbable for the fictional parents in the TV sitcom 'Malcolm in the Middle' to have five sons or for the Bennet family in 'Pride and Prejudice' to have five daughters. Even in history, patterns like this have drawn attention. King Louis VII of France, for example, remarried after his first two wives each gave birth to daughters, depriving him of a male heir.
Chavarro said it might take years to fully understand why some families consistently have children of one sex, but this research is an important place to start.
His team said future studies should explore how lifestyle, nutrition and exposure to environmental chemicals might affect these patterns.
Certain factors such as race, natural hair color, blood type, body mass index and height were not associated with having children of only one sex. But the study sample was 95 percent White and made up entirely of nurses, a group that may have different occupational exposures or health patterns compared with the general population.
David A. Haig, an evolutionary biologist at Harvard University who was not involved in the study, said it offers evidence that the probability of a baby's sex varies by family.
'Different families are flipping different coins with different biases,' Haig said. 'It speaks to something very intuitive and personal, even if the underlying biology is complex.'
Related Content
Family adopts a shelter dog — then learns he's the father of their late dog
Can the Fed stay independent? Trump-era adviser may put it to the test.
The Hubble telescope zooms in on the galaxy next door
Solve the daily Crossword
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Yahoo
11 minutes ago
- Yahoo
GSK climbs after winning FDA priority review for oral gonorrhoea antibiotic
-- GSK (NYSE:GSK) (LON:GSK) said on Monday that the U.S. Food and Drug Administration has accepted its priority review application for gepotidacin, an oral antibiotic aimed at treating sexually transmitted uncomplicated gonorrhoea. The drugmaker's shares climbed 1% in London on the news. The company is looking to new infectious disease products, including its recently launched respiratory syncytial virus vaccine, to offset expected revenue declines from top-selling medicines and looming patent expirations in its HIV portfolio. Gepotidacin is already approved in the U.S. under the brand name Blujepa for treating a common urinary tract infection in women and adolescent girls. The FDA is expected to decide in December on its use for uncomplicated urogenital gonorrhoea, which could offer patients an oral alternative to existing injectable treatments. Separately, GSK and Germany's CureVac last week resolved a long-running patent dispute with Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) over mRNA vaccine technology used during the COVID-19 pandemic. The settlement follows BioNTech's June agreement to acquire CureVac in an all-stock deal worth $1.25 billion to advance work on mRNA-based cancer therapies. Under the settlement, CureVac and GSK will receive $740 million and single-digit percentage royalties on future U.S. sales of COVID-19 vaccines, CureVac said. GSK's share amounts to $370 million, including $50 million to adjust terms from a 2024 licence agreement that expanded their pandemic-era partnership. If BioNTech's takeover of CureVac is completed, related mRNA litigation outside the U.S. will also be resolved, with GSK receiving an additional $130 million and royalties extended to non-U.S. sales. CureVac said the acquisition remains on track under the agreed terms. GSK said it still has separate patent cases against Pfizer and BioNTech in the U.S. and Europe, which are unaffected by this settlement. Related articles GSK climbs after winning FDA priority review for oral gonorrhoea antibiotic USPS blocks major vape distributor over unregulated product shipments - Reuters Exclusive: Opendoor CEO Wheeler breaks silence, EMJ's Eric Jackson calls for more Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Ben Askren Reveals What Awakened in Him After His 45-Day Coma
Ben Askren Reveals What Awakened in Him After His 45-Day Coma originally appeared on Athlon Sports. Ben Askren opens up after dying four times and waking from a 45-day coma The combat sports world has seen its share of comebacks—but none like this. After a 45-day coma, multiple cardiac arrests, and a life-saving double lung transplant, former UFC star Ben Askren has returned home and broken his silence. The 41-year-old revealed that he flatlined not once, but four times while battling a severe staph infection that left him on life support. What followed wasn't just a physical transformation—it was a spiritual one. In a clip shared by Happy Punch, Askren confirmed that he woke up from his coma with a newfound faith after 15 years of denying Christianity. 'I woke up and I started as a Christian. I hadn't gone with my wife to church for 15 years—that was part of the deal. I said, 'I'm not a Christian, but I will support you.' When I woke up, I knew I had to do it.' he revealed in an emotional video posted to social media. He's now focused on recovery after spending 59 days in the hospital—but the journey has taken another turn. Askren is currently back in the hospital following concerns over a suspected chest tube infection, as reported by Yahoo Sports. He's receiving antibiotics and undergoing additional imaging to monitor the situation. While it's a discouraging setback, Askren has remained positive, acknowledging that healing isn't always a straight line and expressing hope to be back home soon. Askren's battle isn't over—but his second act is just beginning. With each step forward and every obstacle faced, he continues to show the same resilience that once made him a champion in the cage—only now, the fight is for something far greater than a title. This story was originally reported by Athlon Sports on Aug 7, 2025, where it first appeared.
Yahoo
an hour ago
- Yahoo
'Alien: Earth' Is Surprisingly Cinematic, a Bit Gross and a Whole Lot of Awesome
If you ask me, it's a great time to be an Alien fan. Last year's Alien: Romulus offered a fun, nostalgic taste of what made the Alien movies so iconic. It was the perfect appetizer for what's coming next. Of course, I am speaking about Alien: Earth. It's been about five years since FX officially announced the Noah Hawley project and, now, with the show just days away from premiering (the first two episodes drop on Tuesday, Aug. 12, on Hulu, FX and Disney Plus), I am here to squash your worries. Alien: Earth is good. In fact, it's pretty epic. Heck, I'd go so far as to say it's the best Alien story I've seen since James Cameron put Sigourney Weaver in a power loader back in 1986. Needless to say, I have a lot to say about the eight episodes I've seen -- and I'm going to do so as spoiler-free as possible. Still, if you want to avoid any details about the show, I advise you to tread lightly. Read more: Hulu to Fully Combine With Disney Plus and Expand Globally: What We Know Alien: Earth does something no other installment of the franchise has dared to do: It puts the majority of the story on Earth. The year is 2120, just two years before Ellen Ripley's (Weaver) fight for survival takes place on the Nostromo. In this world, five tech corporations govern the people: Prodigy, Weyland-Yutani, Lynch, Dynamic and Threshold. Up until now, we've only heard of Weyland-Yutani. Adding the other companies to the mix and exploring their political conflicts and fight for power opens up the story and broadens things a bit from the usual monster-versus-innocent-crew-members formula we've come to expect from an Alien story. The Xenomorph is still very much the focal point of the series, don't get me wrong. However, Alien: Earth introduces a few new concepts to the mix: Cyborgs (humans augmented with machine parts), hybrids (synthetic bodies controlled by human consciousness) and a collection of insidious space insects that add new horrors besides the face-hugging variety. You can't really replicate the initial shock that audiences felt after watching Alien for the first time. Sure, a chest-bursting sequence in an Alien movie can be unsettling to watch. But these gruesome scenes are expected and have become formulaic. Hawley knows this and that's why he and his team brought an assortment of creepy-crawlies to the mix. The result is gross and gory; the inclusion of these space bugs delivers a collection of body horror sequences that left me, more than once, shouting in disgust at the TV. That's high praise coming from me. Building an original world such as this is only as enthralling as the characters who populate it and the talent slate really delivers the emotional stakes on all accounts. While Timothy Olyphant is the biggest name on the call sheet, each of the main players -- Sydney Chandler (who plays Wendy), Alex Lawther (who plays Hermit), Samuel Blenkin (who plays Boy Kavalier) and Babou Ceesay (who plays Morrow) -- delivers tenfold. Audiences have never seen Olyphant play a character like the synthetic Kirsh. He's enigmatic in his stillness and leaves you regularly guessing whose side he is on. As wonderful as he is, it's Chandler who carries the show. Wendy is the emotional entry point for the audience and probably the most complex of all the characters. She is also an advanced synthetic human infused with the consciousness of a child. Her youthful discovery of the world around her bumps up against her newfound responsibility to Prodigy, the company in charge of her synth existence. She strives to reconcile her human identity of the past while trying to make sense of her technological one of the present. Yeesh, talk about an identity crisis. The Alien franchise has regularly pondered whether humanity deserves to survive. The series asks the same question, whether it's in the face of the alien invaders or the corporatations bending the understanding of what it even means to be human. Transhumanism, mortality, corporate control and the perils of unchecked technological advancements are some of the heady themes explored here. As big as some of these creative swings get, you shouldn't worry: aliens are still killing people. The more things change, the more they stay the same. Stylistically, Alien: Earth regularly references the first two Alien movies. That said, there is ample room to create something new and explore uncharted ground in the process. And the show does just that. The result is a program that is grand in scope, and while familiar visuals and aesthetics are featured throughout, Alien: Earth is delightfully different. This brings me to the Xenomorph. I'm not sure how practical the effects are in reference to the iconic creature (it's clear in some scenes that there's a person inside of a costume), but there are shots featured throughout the show that present the monster in a unique perspective, unlike anything I've seen before. And instead of waiting multiple episodes before the big bad is revealed, it's set loose in the pilot episode. Through his TV work with Fargo and Legion, Noah Hawley has established a tone and flavor for his projects, and that offbeat energy can most definitely be found here. His fingerprints are all over this show (he even makes an on-screen cameo), and this is mostly a good thing. That said, if I were to really nitpick, it'd be the slow-burn pacing featured throughout the season that I'd take issue with. Still, that's a minor flaw to me, which is totally made up for with every banging needle drop that closes out each episode. It's probably evident that I am a huge Alien fan. I get the references and smile every time I see a style note or referential homage. That said, the show is surprisingly low on Easter eggs, which is great. It respects and honors what came before it without getting lost in the minutiae. Alien: Earth has equal appeal to newbies who have never seen an Alien movie and die-hard franchise fanatics like myself. I can honestly say this series is unlike anything I've seen in the Alien universe. It's familiar while also being new; it's different without being destructive to the lore. Alien fans have trudged through one disappointing movie after another to get here. Alien: Earth is a win, and I'm ecstatic. You could even say my chest is bursting with joy. It only took four decades to get here. I guess good things really do come to those who wait. Solve the daily Crossword